Apex Health Secures Five Prestigious Awards for Patient Experience Excellence from Arab Hospitals Federation

Qatar’s The View Hospital, in affiliation with Cedars-Sinai, earned Gold Awards in Safety and Quality of Care and Continuity of Care & Transition Management The Military Medical City Hospital, managed by EWS, Qatar, received Silver in Sustainability, Innovation & Technology Al Imam Al Hassan Al Mujtaba Teaching Hospital, Iraq, awarded Silver in Safety and Quality … [Read more…]

Anova Launches Global Clinical Registry to Accelerate Research and Access to Promising New Treatments

Anova has launched a global clinical registry to accelerate patient recruitment, speed accrual for sponsors of clinical trials globally AnovaOS® global clinical registry provides a rich source of real-world data to inform clinical decision-making in clinical trials Registry quality data can be used to support post-market surveillance programs, data-driven study design, and marketing approvals The … [Read more…]

Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:00 a.m. EST on Tuesday, November 4, 2025. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s Third Quarter … [Read more…]

Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery

Collaboration aims to discover and develop novel small molecule therapeutics against two targets designated by Merck VANCOUVER, British Columbia–(BUSINESS WIRE)–#AIDD—Variational AI, Inc., a generative AI drug discovery company, today announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply Variational AI’s Enki™ platform to design and optimize novel … [Read more…]

Healx Strengthens Focus on Preventing Cancer Recurrence by Leveraging Its AI-Powered Platform and Advancing Its Oncology Pipeline Through a Strategic Transaction with Vuja De Sciences

CAMBRIDGE, England–(BUSINESS WIRE)–Healx, the AI-powered biotech company pioneering the next generation of drug discovery for rare diseases, today announced it has entered into a strategic transaction with Vuja De Sciences, a US-based biotech company focused on addressing cancer recurrence and metastatic endurance. Healx’s proprietary AI platform has uncovered and prioritised therapeutic opportunities across rare diseases … [Read more…]

Sensory Cloud Announces Positive Results from the Phase 2 REACH Trial at King Saud University Medical City in Patients with Refractory Chronic Cough (RCC)

Daily treatment with SC0023 yielded treatment efficacy 53.5% ± 19.2% relative to baseline in 24-hour daily cough rate and 19.5% ± 6.2% placebo effect Cough rate reduction was observed from the first day of dosing and across baseline cough rates ranging from 5 to 25 coughs/hour Persistent cough suppression post-treatment was also observed across cough … [Read more…]

Ardent Announces Successful Amendment and Extension of Term Loan Facility

BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that it has successfully amended and extended its $777.5 million Term Loan Facility. The new terms reduce the applicable interest rate by 50 basis points from Term Secured Overnight Financing Rate (SOFR) plus 2.75% … [Read more…]

Samuel Merritt University Expands Nursing Programs to Help Close California’s Nursing Shortage

OAKLAND, Calif.–(BUSINESS WIRE)–As California faces a critical shortage of registered nurses, Samuel Merritt University (SMU), a leader in health science education for over a century, is taking action to grow the nursing workforce and expand access to quality care across the state. SMU today announced a significant expansion of its nursing programs across multiple campuses, … [Read more…]

Onego Bio Receives FDA “No Questions” Letter on GRAS Status of Bioalbumen®

SAN DIEGO–(BUSINESS WIRE)–Onego Bio, a food ingredient company producing egg protein through precision fermentation, announced today that the U.S. Food and Drug Administration (FDA) has issued a “no questions” letter regarding the company’s conclusion that its flagship product, marketed as Bioalbumen®, is Generally Recognized As Safe (GRAS) under its conditions of use in a wide … [Read more…]

Confluence Genetics Partners With Ag Partners Cooperative to Increase Commercial Acres of ProVIA™ Soybeans Following Successful Broiler Performance Trials

Following initial trial with a large poultry integrator completed September 2024, second trial validates benefits and companies offer identity preserved grower programs for 2026 crop. Consistent Results: Confluence Genetics’ second broiler trial with a major poultry integrator confirmed that soybean meal derived from ProVIA™ soybeans improves broiler performance, delivering 2.2% higher final body weight and … [Read more…]